Olympus Corporation (OCPNF)
OTCMKTS · Delayed Price · Currency is USD
12.42
+0.57 (4.85%)
At close: Sep 9, 2025
Olympus Market Cap
Olympus has a market cap or net worth of $13.53 billion as of October 14, 2025. Its market cap has decreased by -34.46% in one year.
Market Cap
13.53B
Enterprise Value
13.76B
Revenue
6.72B
Ranking
n/a
PE Ratio
17.38
Stock Price
$12.42
Market Cap Chart
Since January 16, 1992, Olympus's market cap has increased from 2.39B to 13.53B, an increase of 465.23%. That is a compound annual growth rate of 5.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 13.19B | -22.47% |
| Dec 30, 2024 | 17.01B | -1.61% |
| Dec 29, 2023 | 17.29B | -23.63% |
| Dec 30, 2022 | 22.64B | -23.48% |
| Dec 30, 2021 | 29.58B | 5.35% |
| Dec 30, 2020 | 28.08B | 40.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |